findmyKOL
Clinical trialNCT05436652CompletedPhase 2Interventional

A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)

SponsorSparrow PharmaceuticalsEnrollment66Polymyalgia Rheumatica
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This will be a single-blind, placebo-controlled phase 2 trial to compare prednisolone effects with and without SPI-62 in participants with PMR.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Universitätsmedizin Berlin, Medizinische Klinik Mit Schwerpunkt Rheumatologie Und Klinische Immunologie

    Berlin, Germany

  • Internistische Praxisgemeinschaft Rheumatologie Nephrologie

    Erlangen, Germany

  • Hamburger Rheuma Forschungszentrum Ii Im Mvz Für Rheumatologie Und Autoimmunmedizin

    Hamburg, Germany

  • Katholische Kliniken Rhein-Ruhr Am Marien Hospital, Universitätsklinik Der Ruhr-Universität

    Herne, Germany

  • Universitätsmedizin Der Johannes Gutenberg Universität Mainz

    Mainz, Germany

  • Praxis Prof. Dr. Med. Herbert Kellner

    Munich, Germany

Poland
  • Novareuma

    Bialystok, Poland

  • the University of Gdańsk

    Gdansk, Poland

  • Mics Centrum Medyczne Warszawa

    Warsaw, Poland

  • Dolnośląski Szpital Specjalistyczny Im. T. Marciniaka

    Wroclaw, Poland

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Additional prednisoloneAdditional prednisolone matched placeboPrednisolone →SPI-62SPI-62 matched placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Jul 2022
Primary completion
25 Apr 2025
Completion
25 Apr 2025
Last update posted
11 May 2025
Registered enrollment
66
Registry id
NCT05436652
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.